1. Yao, Xiaosai, Hong, Jing Han, Nargund, Amrita M, Tan, Patrick, Teh, Bin Tean. 2023. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma. In Nature cell biology, 25, 765-777. doi:10.1038/s41556-023-01122-y. https://pubmed.ncbi.nlm.nih.gov/37095322/
2. . . Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. In Cancer cell, 32, 185-203.e13. doi:10.1016/j.ccell.2017.07.007. https://pubmed.ncbi.nlm.nih.gov/28810144/
3. Xin, Qiliang, Feng, Iris, Yu, Guoyun, Dean, Jurrien. 2024. Stromal Pbrm1 mediates chromatin remodeling necessary for embryo implantation in the mouse uterus. In The Journal of clinical investigation, 134, . doi:10.1172/JCI174194. https://pubmed.ncbi.nlm.nih.gov/38426493/
4. Jonasch, Eric, Walker, Cheryl Lyn, Rathmell, W Kimryn. 2020. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. In Nature reviews. Nephrology, 17, 245-261. doi:10.1038/s41581-020-00359-2. https://pubmed.ncbi.nlm.nih.gov/33144689/
5. Miao, Diana, Margolis, Claire A, Gao, Wenhua, Choueiri, Toni K, Van Allen, Eliezer M. 2018. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. In Science (New York, N.Y.), 359, 801-806. doi:10.1126/science.aan5951. https://pubmed.ncbi.nlm.nih.gov/29301960/
6. Motzer, Robert J, Banchereau, Romain, Hamidi, Habib, Huseni, Mahrukh A, Rini, Brian. 2020. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. In Cancer cell, 38, 803-817.e4. doi:10.1016/j.ccell.2020.10.011. https://pubmed.ncbi.nlm.nih.gov/33157048/
7. Farnaby, William, Koegl, Manfred, Roy, Michael J, McConnell, Darryl B, Ciulli, Alessio. 2019. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. In Nature chemical biology, 15, 672-680. doi:10.1038/s41589-019-0294-6. https://pubmed.ncbi.nlm.nih.gov/31178587/
8. Pan, Deng, Kobayashi, Aya, Jiang, Peng, Liu, X Shirley, Wucherpfennig, Kai W. 2018. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. In Science (New York, N.Y.), 359, 770-775. doi:10.1126/science.aao1710. https://pubmed.ncbi.nlm.nih.gov/29301958/
9. Cotta, Brittney H, Choueiri, Toni K, Cieslik, Marcin, Ari Hakimi, A, Salami, Simpa S. 2023. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. In European urology, 84, 166-175. doi:10.1016/j.eururo.2023.04.003. https://pubmed.ncbi.nlm.nih.gov/37085424/
智鼠故事 
